摘要
目的探究胫骨高位截骨结合荣筋壮骨汤内服治疗膝关节内侧单间室骨性关节炎的临床疗效。方法选择关节外科2017年1月-2019年3月间就诊的膝关节内侧单间室骨性关节炎并膝内翻畸形患者40例,根据随机数字表法将所有患者分为对照组与观察组,每组各20例。对照组实施胫骨高位截骨术治疗,观察组在对照组基础上联合中药荣筋壮骨汤内服治疗,对比两组疗效、VAS评分及HSS评分差异。结果观察组总有效率高于对照组,差异有统计学意义(P <0. 05)。治疗前两组VAS评分、HSS评分未见明显差异(P> 0. 05);治疗后1个月、3个月观察组VAS评分低于对照组,HSS评分高于对照组,差异有统计学意义(P> 0. 05)。结论胫骨高位截骨手术联合荣筋壮骨汤内服治疗膝关节内侧单间室骨性关节炎并膝内翻畸形患者,临床价值高,患者预后良好。
Objective To explore the clinical effect of high tibial osteotomy combined with Rongjin Zhuanggu decoction for the treatment of medial unicellular osteoarthritis of knee joint. Methods Forty-six patients with knee joint medial single-compartment osteoarthritis and knee varus deformity from January 2017 to March 2019 were selected. All patients were divided into control group and observation group according to random number table method. Each group has 20 cases.The control group was treated with high tibial osteotomy. The observation group was treated with Chinese medicine Rongjin Zhuanggu Decoction on the basis of the control group. The differences in efficacy,VAS score and HSS score were compared between the two groups. Results The total effective rate of the observation group was higher than that of the control group,and the difference was statistically significant( P < 0. 05). There was no significant difference in VAS score and HSS score between the two groups before treatment( P > 0. 05). The VAS score of the observation group was lower than that of the control group and HSS score was higher than that of the control group 1 month and 3 months after treatment,the difference was statistically significant( P > 0. 05). Conclusion High-level osteotomy surgery combined with Rongjin Zhuanggu Decoction for the treatment of knee joint medial single-compartment osteoarthritis with knee varus deformity has high clinical value and good prognosis.
作者
钟宏发
林永飞
邱崇慧
ZHONG Hongfa;LIN Yongfei;QIU Chonghui(Ganzhou Hospital of Traditional Chinese Medicine, Ganzhou 341000, China)
出处
《现代医院》
2019年第9期1368-1370,共3页
Modern Hospitals
基金
江西省卫生计生委中医药科研课题(2018A266)